Skip to main content

Myopia Control

  • Chapter
  • First Online:
Optics for the New Millennium
  • 624 Accesses

Abstract

This chapter will review new concepts and practices regarding clinical management of myopia in the pediatric population. This topic has garnered significant attention in the recent years with new philosophies emerging in regards to various methods to slow myopic progression in children. Several Optics topics that are discussed in other chapters of this text will have significant relevance here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Dirani M, Shekar SN, Baird PN. Adult-onset myopia: the Genes in Myopia (GEM) twin study. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3324–7.

  2. 2.

    Lyhne N, Sjølie AK, Kyvik KO, Green A. The importance of genes and environment for ocular refraction and its determiners: a population based study among 20–45 year old twins. Br J Ophthalmol. 2001 Dec;85(12):1470–6.

  3. 3.

    Mutti DO, Mitchell GL, Moeschberger ML, Jones LA, Zadnik K. Parental myopia, near work, school achievement, and children’s refractive error. Invest Ophthalmol Vis Sci. 2002 Dec;43(12):3633–40.

  4. 4.

    Kleinstein RN, Sinnott LT, Jones-Jordan LA, Sims J, Zadnik K; Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error Study Group. New cases of myopia in children. Arch Ophthalmol. 2012 Oct;130(10):1274–9.

  5. 5.

    French AN, Morgan IG, Burlutsky G, Mitchell P, Rose KA. Prevalence and 5- to 6-year incidence and progression of myopia and hyperopia in Australian schoolchildren. Ophthalmology. 2013 Jul;120(7):1482–91.

  6. 6.

    Guo Y, Liu LJ, Tang P, Lv YY, Feng Y, Xu L, Jonas JB. Outdoor activity and myopia progression in 4-year follow-up of Chinese primary school children: The Beijing Children Eye Study. PLoS One. 2017 Apr 27;12(4):e0175921

  7. 7.

    Tasks with high near-vision demands include use of hand-held electronic devices, video games, etc. Perhaps your mom was right after all: too much TV will ruin your eyes and you should go play outside more!

  8. 8.

    Wong TY, Klein BE, Klein R, Knudtson M, Lee KE. Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology 2003;110:211–7.

  9. 9.

    Leske MC, Wu SY, Nemesure B, Hennis A. Risk factors for incident nuclear opacities. Ophthalmology 2002;109:1303–8.

  10. 10.

    Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt 2005;25: 381–91.

  11. 11.

    Risk factors for idiopathic rhegmatogenous retinal detachment. The Eye Disease Case-Control Study Group. Am J Epidemiol 1993;137: 749–57.

  12. 12.

    Schaeffel F, Howland HC. Properties of the feedback loops controlling eye growth and refractive state in the chicken. Vision Res 1991; 31:717–34. 66.

  13. 13.

    Hung LF, Crawford ML, Smith EL, III. Spectacle lenses alter eye growth and the refractive status of young monkeys. Nat Med 1995; 1:761–5

  14. 14.

    Smith EL, III, Huang J, Hung LF, Blasdel TL, Humbird TL, Bockhorst KH. Hemiretinal form deprivation: evidence for local control of eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci 2009;50:5057–69.

  15. 15.

    Smith EL, III, Hung LF, Huang J, Blasdel TL, Humbird TL, Bockhorst KH. Effects of optical defocus on refractive development in monkeys: evidence for local, regionally selective mechanisms. Invest Ophthalmol Vis Sci 2010;51:3864–73

  16. 16.

    Hoogerheide J Rempt F Hoogenboom W. Acquired myopia in young pilots. Ophthalmologica. 1971; 163: 209–215.

  17. 17.

    This is how we imagine the brain and the eye communicate, and we dare you to prove us wrong.

  18. 18.

    WSPOS – World Society of Pediatric Ophthalmology and Strabismus WSPOS Myopia Consensus Statement −2019

  19. 19.

    Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev.; 2011. CD004916

  20. 20.

    Walline JJ, Walker MK, Mutti DO, Jones-Jordan LA, Sinnott LT, Giannoni AG, Bickle KM, Schulle KL, Nixon A, Pierce GE, Berntsen DA; BLINK Study Group. Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial. JAMA. 2020 Aug 11;324(6):571–580.

  21. 21.

    Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom Vis Sci. 2019;96(8):556–567.

  22. 22.

    VanderVeen DK, Kraker RT, Pineles SL, Hutchinson AK, Wilson LB, Galvin JA, Lambert SR. Use of Orthokeratology for the Prevention of Myopic Progression in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2019 Apr;126(4):623–636.

  23. 23.

    Barathi VA, Beuerman RW. Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: prior to and after induction of experimental myopia with atropine treatment. Mol Vis. 2011;17:680–692

  24. 24.

    Pineles SL, Kraker RT, VanderVeen DK, Hutchinson AK, Galvin JA, Wilson LB, Lambert SR. Atropine for the Prevention of Myopia Progression in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017 Dec; 124(12):1857–1866.

  25. 25.

    Chia A, Lu QS, Tan D. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. (ATOM2) Ophthalmology. 2016 Feb;123(2):391–9

  26. 26.

    Yam JC, Li FF, Zhang X, Tang SM, Yip BHK, Kam KW, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report. Ophthalmology. 2020 Jul; 127(7):910–919.

  27. 27.

    Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kaburaki T, Kakehashi A. Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial. Sci Rep. 2020 Jul 29; 10(1):12750.

  28. 28.

    Zhang X, Tao XC, Zhang J, et al. A review of collagen crosslinking in cornea and sclera. J Ophthalmol. 2015; 2015: 289467.

Acknowledgements

The author would like to thank Dr. Gary Gerber, OD, Co-Founder, Chief Myopia Eradication Officer, Treehouse Eyes; Dr Rachel M. Caywood, OD, FAAO, Dean McGee Eye Institute / University of Oklahoma; and Dr. Ashley Wong, OD, Eye Doctors of Washington for their guidance in this subject.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Vike Vicente .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vicente, G.V. (2022). Myopia Control. In: Riaz, K.M., Vicente, G.V., Wee, D. (eds) Optics for the New Millennium. Springer, Cham. https://doi.org/10.1007/978-3-030-95251-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-95251-8_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-95250-1

  • Online ISBN: 978-3-030-95251-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics